Dementia Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Increasing prevalence of Alzheimer disease and increasing geriatric population are major factors driving the growth of the Global Dementia Drugs Market.
Dementia Drugs Market is valued at USD 15535.2 Million in 2018 and expected to reach USD 32662.5 Million by 2025 with the CAGR of 11.20% over the forecast period.
Dementia is a syndrome of loss of cognitive functioning such as; thinking, remembering, and reasoning and behavioral abilities to such an extent that it interferes with a person’s daily life and activities. It occurs when the parts of the brain used for learning, memory, decision making and language are damaged or diseased. It has major impact on memory, thinking, orientation, comprehension, calculation, learning capacity, language and judgment. But the consciousness is not affected. It is one of the major reason of disability and dependency of older people globally. In older population, Alzheimer’s disease is the most common cause of a progressive dementia but there are various other factors also which causes the dementia. Depending on the cause, some of the dementia cases may be reversible. majorly affects people of aged 65 years and above. Currently, there is no curative therapy available for dementia disease. However, drugs for dementia therapy are in pipeline, which are expected to be launched in the near future, in turn propelling growth of the dementia drugs market.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=59525&RequestType=Sample
Global dementia drugs market report is segmented on the basis of drug class, distribution channel and region & country level. Based upon drug class, dementia drugs market is classified into MAO inhibitors, glutamate inhibitors and cholinesterase inhibitors. On the basis of distribution channel, market is classified into retail pharmacies, hospital pharmacies and others.
The regions covered in this Global Dementia Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of dementia drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Dementia Drugs Market Report-
Some major key players for global dementia drugs market are Eisai, Inc., Janssen Pharmaceuticals, Inc., Biogen Pharmaceuticals, Forest Laboratories, Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, AstraZeneca GmbH, F. Hoffmann-La Roche, Merck & Co., Inc., Valeant Pharmaceutical International, Pfizer Inc., and Teva Pharmaceuticals Industries Ltd.
Growing Number of Pipeline Products and Increasing Geriatric Population are Expected to Drive the Growth of the Dementia Drugs Market.
Increasing number of incidences of dementia cases is one of the major factors driving the growth of global dementia drugs market. For example: As per the Alzheimer’s Disease International; Someone in the world develops dementia every 3 seconds. There were an estimated 46.8 million people worldwide living with dementia in 2015 and this number is believed to be close to 50 million people in 2017. This number will almost double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Much of the increase will be in developing countries. Already 58% of people with dementia live in low and middle income countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbors. In addition, increasing aging population along with its associated complications is also supplementing the market growth. However, the high cost of prospective drugs to be marketed may hamper the growth of the market. However, increasing research and development in this field may provide various opportunities for this market.
North America is expected to dominate the Dementia Drugs Market.
By region, the global dementia drugs market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is expecetd to dominate the market and is expected to continue owing to the favorable government reimbursement policies in this region. The United States holds the largest share of the global Alzheimer’s disease diagnostics and therapeutics market. According to the Alzheimer’s Association, more than 5 million Americans suffer from Alzheimer’s, as of 2017. The Asia Pacific Alzheimer’s drugs market, is anticipated to witness a significant growth with the highest CAGR owing to the growing awareness about neurodegenerative diseases in developing regions.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=59525&RequestType=Methodology
Key Benefits for Dementia Drugs Market Report–
- Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in market place.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Global Dementia Drugs Market Segmentation:
By Drug Class:
- MAO Inhibitors
- Glutamate Inhibitors
- Cholinesterase Inhibitors
By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
By Regional & Country Level:
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- Middle East and Africa
- Rest of Middle East and Africa
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Dementia-Drugs-Market-Size/Summary
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at email@example.com